Another study was able to support a diagnosis of primary dysferlinopathy in symptomatic carriers with findings of abnormal dysferlin gene expression in skeletal muscle and monocytes [26]. This evidence concerns the gene DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.